Industry Relations Hub Login
MEMBER LOGIN
Search
START TYPING AND PRESS ENTER TO SEARCH

How PBMs Work

How PBMs Work

PBMs Work At the Center of Health and Savings
‍Pharmacy benefit companies are working every day on behalf of employers and health plans to secure savings on prescription drugs, enable better health outcomes for patients, and support access to quality prescription drug coverage for more than 275 million patients.
LEARN MORE

Stepping Toward a More Affordable Future

Stepping Toward a More Affordable Future

PBMs provide $145 billion in value for the U.S. health care system annually by lowering prescription drug costs. Additionally, PBMs enable better health outcomes for patients and offer employers and other health insurance plan sponsors the choices and guidance they need to expand access and provide quality prescription drug coverage for millions of Americans.
LEARN MORE

LATEST NEWS:

New Year, Same Fact: PBMs Play Critical Role Driving Down Health Costs

LATEST NEWS

As Washington welcomes a new Congress, it’s a good time to revisit the critical, cost-saving role pharmacy benefit managers (PBMs) play in the prescription drug supply chain as well as caution policymakers against policies that intrude into the commercial market.
READ MORE

PCMA Events

PCMA hosts two annual conferences exclusively for our members, sponsors and their affiliated business partners

Learn More
See Past Events >

PCMA Industry Relations Hub

For detailed event information, photos, videos, and more, head to the PCMA Industry Relations Hub.

IR HUB

Thought Leadership

Fostering a More Culturally Competent Health Care System

DEI RESOURCES

PCMA is committed to working toward a more equitable health care system. One key component to advancing health care equity and reducing health disparities is advancing culturally competent care.
LEARN MORE

PBMs and Pharmacies

PBMs AND PHARMACIES

Each year, PBMs save patients and the U.S. health care system an average of $1,040 per person. Without PBMs, employers and health plans would be forced to go it alone on pharmacy benefits, which would result in significantly higher drug costs for patients.
LEARN MORE

FEATURED INFOGRAPHIC

GLP-1s for Weight Loss and How PBMs Are Rising to the Challenges

Semaglutide, liraglutide, and tirzepatide are all glucagon-like peptide-1 (GLP-1)1 agonists initially approved by the U.S Food and Drug Administration (FDA) for type 2 diabetes and more recently for weight management.
LEARN MORE

Health Equity

HEALTH EQUITY

Pharmacy benefit companies, in collaboration with plan sponsors, clinicians, and government programs, have a long history of working to advance health equity; however, the severity of the health disparities revealed during the COVID-19 pandemic spurred the Pharmacy Benefit Managers (PBMs) industry to develop a more unified response.
LEARN MORE